U.S. Market Expected to Hit USD 1.80 Billion by 2035; Europe Projected to Reach USD 1.67 Billion as Rare Disease Screening Programs Expand.Austin, United States, June 08, 2026 (GLOBE NEWSWIRE) -- “As ...
There was a time when pregnancy tests did not merely announce impending parenthood. They opened the door to nine months of ...
For decades, the accepted explanation for the origins of the Japanese people was relatively straightforward. Modern Japanese ...
Experts say growing awareness about the difference between screening and diagnostic tests can help families make informed ...
The Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific is designed for fast, scalable sample analysis. Paired with the Applied Biosystems Axiom™ PharmacoPro™ Array ...
Definition: A microarray is a small, flat substrate carrying an ordered grid of microscopic probe features, each containing a known biological molecule, that is used to measure many molecular targets ...
The DNA microarray market is witnessing steady growth due to the rising demand for advanced genomic research, personalized medicine, and early disease diagnosis. The increasing prevalence of cancer, ...
The best home DNA kits can provide a window into our ancestry, genetic traits, and overall health. They can trace family roots, uncover inherited traits and even help you connect with distant ...
JA Rosenfeld is an employee of Signature Genomic Laboratories, a subsidiary of PerkinElmer, Inc. The authors have no other relevant affiliations or financial involvement with any organization or ...
There are two key things to know about the new Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results